EP 1165098 A2 20020102 - PEROXOVANADIUM COMPOUNDS AS ANTINEOPLASTIC AGENTS FOR THE TREATMENT OF CANCER
Title (en)
PEROXOVANADIUM COMPOUNDS AS ANTINEOPLASTIC AGENTS FOR THE TREATMENT OF CANCER
Title (de)
PEROXOVANADIUM VERBINDUNGEN ALS ANTINEOPLASTICHE MITTEL ZUR BEHANDLUNG VON KREBS
Title (fr)
COMPOSES DE PEROXOVANADIUM UTILISES COMME AGENTS ANTINEOPLASIQUES DANS LE TRAITEMENT DU CANCER
Publication
Application
Priority
- CA 0000320 W 20000323
- US 12637699 P 19990326
Abstract (en)
[origin: WO0057860A2] The present invention relates to the use of peroxovanadium compounds as antineoplastic agents for the treatment of cancers, particularly solid tumor malignancies. Further, this invention is directed to the use of modifications to the heteroligand structure of organified peroxovanadium compounds to modulate their activities against specific intracellular targets such as, but not limited to, the CDC 25 family of phosphatases, that may be directly involved in the pathogenesis of cancer.
IPC 1-7
IPC 8 full level
A61K 31/28 (2006.01); A61K 31/555 (2006.01); A61P 35/00 (2006.01)
CPC (source: EP)
A61K 31/28 (2013.01); A61K 31/555 (2013.01); A61P 35/00 (2017.12)
Citation (search report)
See references of WO 0057860A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0057860 A2 20001005; WO 0057860 A3 20010405; AU 3412600 A 20001016; CA 2365122 A1 20001005; EP 1165098 A2 20020102
DOCDB simple family (application)
CA 0000320 W 20000323; AU 3412600 A 20000323; CA 2365122 A 20000323; EP 00912300 A 20000323